Skip to main content

Table 2 Weight-related and plasma measurements of female Wistar rats after 8 weeks of dietary treatments

From: Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet

 

Female dietary groups

C (n = 7)

HFS (n = 9)

HFSsupp (n = 10)

ANOVA

Weight-related measurements

Weight gain (g)

68.7 ± 5.9a

102.8 ± 8.9b

109.4 ± 11.4b

*

Subcutaneous WAT ( %)

1.40 ± 0.14a

2.02 ± 0.26a,b

2.27 ± 0.28b

*

Retroperitoneal WAT ( %)

1.87 ± 0.19a

2.70 ± 0.29b

3.09 ± 0.24b

**

Epididymal WAT (%)

2.42 ± 0.30a

3.53 ± 0.49a

3.84 ± 0.41a

ns

Mesenteric WAT (%)

1.28 ± 0.18a

1.63 ± 0.19a

1.62 ± 0.21a

ns

Liver (%)

2.18 ± 0.03a

2.14 ± 0.06a

2.24 ± 0.07a

ns

Gastrocnemius muscle (%)

0.59 ± 0.02a

0.55 ± 0.03a

0.51 ± 0.04a

ns

Plasma values

Glucose (mg/dL)

103.4 ± 6.1a

108.9 ± 3.7a

119.3 ± 6.7a

ns

HDL cholesterol (mg/dL)

56.8 ± 4.3a

40.4 ± 4.6b

54.2 ± 4.5a

*

Triglycerides (mg/dL)

86.5 ± 6.9a

57.7 ± 5.3a

74.1 ± 13.2a

ns

Lactate (mg/dL)

27.8 ± 4.3a

26.1 ± 3.4a

34.3 ± 4.7a

ns

Homocysteine (μmol/L)

15.6 ± 1.1a

15.2 ± 0.8a

14.1 ± 0.9a

ns

Insulin (μU/mL)

15.5 ± 4.7a

16.4 ± 3.3a

21.2 ± 4.5a

ns

  1. All the results are expressed as the mean ± SE. Statistical analyses were performed using one-way Anova and Tukey post hoc test. Different letters (a, b) indicate significant differences between groups of at least p < 0.05
  2. WAT white adipose tissue, C control group, HFS high-fat-sucrose group, HFSsupp high-fat-sucrose supplemented with methyl donors group, ns non statistically significant
  3. * p < 0.05, ** p < 0.01